Skip to search formSkip to main contentSkip to account menu

4-hydroxyifosfamide

Known as: 4-hydroxy-ifosfamide 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Dexamethasone induces the hepatic cytochrome P450 3A and, therefore, is predicted to change the pharmacokinetics, activities, and… 
2004
2004
Trofosfamide (Ixoten; Baxter Oncology, Germany) is an alkylating agent that, as with other oxazaphosphorine derivatives, has to… 
2001
2001
The autoinducible metabolic transformation of the anticancer agent ifosfamide involves activation through 4‐hydroxyifosfamide to… 
2001
2001
The distribution of ifosfamide (IF) and its metabolites 2-dechloroethylifosfamide (2DCE), 3-dechloroethylifosfamide (3DCE), 4… 
1997
1997
Purpose: Ifosfamide is becoming an important clinical anticancer drug. Meaningful pharmacology studies require quantification of… 
1995
1995
There is ongoing interest in the selective, quantitative analysis of the cyclophosphamide metabolites 4-hydroxycyclophosphamide… 
1994
1994
31P nuclear magnetic resonance (NMR) spectroscopy was used in conjunction with cell perfusion techniques to monitor the… 
1989
1989
The activation mechanisms of the N-substituted 4-hydroxycyclophosphamide analogues 4-hydroxyifosfamide (2b), 4… 
1985
1985
A sensitive fluorometric method using 3-aminophenol was developed to measure 4-hydroxyifosfamide, the active metabolite of the… 
1983
1983
The rates at which the 4-hydroxyoxazaphosphorines, 4-hydroxycyclophosphamide and 4-hydroxyifosfamide, are converted to reactive…